戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 an abnormal rhythm discharge with periods of central apnea.
2 espiration in an established animal model of central apnea.
3 w the apneic threshold, thereby resulting in central apnea.
4 associated with suppression of sleep-related central apnea.
5 and alternate apnea type for obstructive and central apnea.
6 nt cause of irregular breathing patterns and central apneas.
7           Also, WHBPs from Mecp2(-/y) showed central apneas.
8                    Most of these events were central apneas.
9 tazolamide, the hourly number of episodes of central apnea (49 +/- 28 vs. 23 +/- 21 [mean +/- SD]; p
10                          Among patients with central apneas, adding dead space decreased sleep fragme
11 reproduces the respiratory phenotype of PWS (central apnea and blunted response to respiratory challe
12                                In older men, central apnea and Cheyne-Stokes respiration predicted in
13                   All 8 animals demonstrated central apnea and hypoventilation, which resulted in the
14 eviously unrecognized neurological features, central apnea and neurogenic upper airway collapse, toge
15                                We found that central apnea and O2 desaturation occurred when seizures
16 ackup rate and wakefulness drive can lead to central apneas and sleep fragmentation, especially in pa
17                                     However, central apnea appeared to account for this monotonic rel
18          Theophylline has been used to treat central apnea associated with Cheyne-Stokes respiration
19                                              Central apnea attack might be occurred in patient with I
20  noninvasive mechanical ventilation to treat central apnea (CA) occurring at night ("sleep apnea") in
21                                              Central apnea, Cheyne-Stokes respiration, and sleep-diso
22 PaCO2 results in ventilatory instability and central apnea during sleep.
23  a 50-fold dose range, significantly reduces central apnea expression during NREM and REM sleep in th
24      Because pressure support predisposes to central apneas in healthy subjects, we examined whether
25  the obstructive apnea-hypopnea index (AHI), central apnea index (CAI >/= 5), and Cheyne-Stokes breat
26 6, 8.7, and 5.3, respectively; all p < 0.05; central apnea index [CAI] of </>/=10 events/h; log-rank
27 : apnea-hypopnea index, central sleep apnea (central apnea index, >/=5 vs. <5), central sleep apnea o
28 eater increases in both mean obstructive and central apnea indices, by 1.75 events per hour (95% conf
29 al cerebral dysfunction, possibly leading to central apnea, may be a pathogenetic mechanism for SUDEP
30                                              Central apneas occur after cessation of mechanical venti
31                                              Central apneas occurred during pressure support in six p
32  2.72-36.50), Cheyne-Stokes respiration with central apnea (OR, 6.31; 95% CI, 1.94-20.51), and apnea-
33  counts), atrial fibrillation was related to central apnea (OR, 9.97; 95% CI, 2.72-36.50), Cheyne-Sto
34 se line; P<0.001), the number of episodes of central apnea per hour (6 +/- 14, vs. 26 +/- 21 and 26 +
35 eep apnea had significantly more episodes of central apnea per hour than those without central sleep
36          The density and average duration of central apneas remained unchanged.
37 diazepines in an established animal model of central apnea, we administered nonhypnotic and hypnotic
38       The former also had significantly more central apnea, which occurred more commonly during non-r
39 , and diaphragmatic activities, resulting in central apnea with laryngeal closure; and (2) these lary

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。